ClinicalTrials.Veeva

Menu

Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway

GlaxoSmithKline (GSK) logo

GlaxoSmithKline (GSK)

Status

Terminated

Conditions

Infections, Papillomavirus

Treatments

Procedure: Cancer Registry of Norway (database)

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This is a register-based, epidemiological study of HPV type distribution in women aged 18 years and above with recurrent conization following a primary conization for high grade lesions/ microinvasive carcinomas. This study will involve data collection from different databases in the Cancer Registry of Norway.

Full description

This protocol posting has been updated following Protocol Amendment 1 (02 April 2010). The sections impacted are: enrolment, outcome measures and eligibility criteria.

Enrollment

410 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All subjects must meet the following criteria at study entry:

  • Women aged 18 years and above at the time of the collection of the primary cone specimen;
  • Who have undergone for the first time a conization due to high grade lesions or microinvasive cervical carcinomas, histologically diagnosed in 2003, with possible extension backwards in time;
  • Availability of recurrent cone specimen with high grade lesions/ microinvasive cervical carcinomas or invasive cervical cancer;
  • Availability in designated local laboratories of the primary and recurrent cone specimens;
  • The cone specimen was adequately preserved;
  • Written informed consent obtained from the subject. If the subject is deceased, the cone and biopsy specimens will be used according to prior approval from the Ethics Committee.

Exclusion criteria

None.

Trial design

410 participants in 1 patient group

Cohort A
Description:
Women aged 18 years and above, diagnosed with high grade lesions or microinvasive cervical carcinomas in primary conization performed and registered in the Cancer Registry of Norway, and presenting with recurrent conization with high grade lesions or microinvasive cervical carcinoma or invasive cervical carcinoma.
Treatment:
Procedure: Cancer Registry of Norway (database)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems